101  0 Kommentare Director/PDMR Shareholding - Seite 2

 

 

 

  Price(s) and volume(s)             Price(s) Volume(s)       1.46p 100,000             d)

 

 

 

 

 

  Aggregated information       - Aggregated volume       - Price       e)

  Date of the transaction

 

  30 April 2024 f)

  Place of the transaction

 

  Aquis Stock Exchange

The Directors of DXS International plc accept responsibility for this announcement.

Enquiries:

David Immelman      (Chief Executive) DXS International plc	01252 719800 david@dxs-systems.com
Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS
www.dxs-systems.co.uk

Corporate Advisor
David Papworth City & Merchant	0207 101 7676

Corporate Broker
Hybridan LLP Claire Louise Noyce	020 3764 2341

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.